The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Kyowa Hakko Kirin's 2012 Japan sales performance.
by Sciterion. for Kyowa Kirin International. XLH Matters – Driving Improved Care in XLH Through a Hybrid Meeting Approach. ... by Sciterion. for Kyowa Kirin International. Within – Stories from AstraZeneca’s Cancer@Work Employee Resource Group.
Kyowa Kirin’s Crysvita (burosumab) will be made available via the ultra-orphan pathway, which will allow eligible adults with symptomatic XLH to access the treatment while the company collects additional ... While Scotland is currently the first in the
The business model of Synaffix is target-specific technology out-licensing, shown through its existing deals with ADC Therapeutics, Mersana Therapeutics, Shanghai Miracogen, Innovent Biologics, ProfoundBio, Kyowa Kirin, Genmab, Macrogenics and
by Kyowa Kirin International with support from Sciterion. X-linked hypophosphataemia (XLH) is a rare, life-long, progressive disease. ... XLH Matters – A New Interactive Meeting Platform Raising Awareness of XLH - by Kyowa Kirin International with
by Kyowa Kirin International with support from Sciterion. X-linked hypophosphataemia (XLH) is a rare, life-long, progressive disease. ... XLH Matters – A New Interactive Meeting Platform Raising Awareness of XLH - by Kyowa Kirin International with
No results were found
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....